HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D
M. Cozzolino +5 more
semanticscholar +1 more source
The challenge of HTLV-1 therapeutics: lessons from anti-protease approaches. [PDF]
Ahmadi Ghezeldasht S +4 more
europepmc +1 more source
HAART and lungs: do HIV protease inhibitors impact cancer risk? [PDF]
Uldrick TS.
europepmc +1 more source
HIV-1 Resistance to Dolutegravir in Benin: The Need to Improve and Strengthen Therapeutic Patient Education Strategies to Achieve the Third Objective 95 of UNAIDS 95-95-95 Target. [PDF]
Tchiakpe E +4 more
europepmc +1 more source
Human CaaX protease ZMPSTE24 expressed in yeast: Structure and inhibition by HIV protease inhibitors. [PDF]
Clark KM +3 more
europepmc +1 more source
Structure-based pharmacophore modeling, high-throughput screening, and molecular dynamics identify a novel DrugBank-derived HIV-1 protease inhibitor. [PDF]
Khazaal Nazal AS +3 more
europepmc +1 more source
HIV protease inhibitors block streptolysin S production. [PDF]
Maxson T +6 more
europepmc +1 more source
Research progress on HIV-1 structural proteins and antiviral therapies. [PDF]
Wang H, Yuan J, Wang H.
europepmc +1 more source

